NIH-funded research R01 grant

Azithromycin added to standard care for kids with severe malnutrition in Africa

Official title: Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition: the AMOUR trial

Funded at Washington University · NIH-11625627 · Data updated 2026-11-12

This project tests whether giving azithromycin as an extra antibiotic to young children with uncomplicated severe acute malnutrition improves weight gain and recovery compared with amoxicillin or placebo.

More Malnutrition research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJune 24, 2026
Project endNovember 30, 2028
Funding year2026
Award (this year)$65,932
NIH project number3R01HD111532-04S1
Project IDNIH-11625627 on NIH RePORTER

Who could benefit from this research

Could help

Children with uncomplicated severe acute malnutrition aged up to 11 years in the study region who can be randomized to one of three arms (azithromycin, amoxicillin, or placebo).

Less likely to help

Some participants may not experience additional benefits if antibiotics do not improve weight gain or recovery.

What this research studies

The study targets children aged up to 11 years with uncomplicated severe acute malnutrition in sub-Saharan Africa. In a randomized trial, participants will receive either azithromycin, amoxicillin, or placebo, with follow-up to track weight gain, nutritional recovery, and gut microbiome changes. The goal is to see if a one-time or scheduled antibiotic can reduce mortality and improve clinical outcomes in this vulnerable group. The approach builds on prior findings that mass azithromycin reduced child mortality and aims to clarify the best antibiotic strategy for SAM in this setting. Results could inform future guidelines for antibiotic use in SAM to improve child health.

Why it matters

Potential benefit: If successful, the trial could lead to more effective antibiotic strategies that improve growth and survival for children with severe malnutrition.

How similar studies have gone: Prior studies showed mixed results for antibiotics in SAM, with some evidence of benefit from azithromycin in population-level outcomes but equipoise at the individual level.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Oldenburg, Catherine Elizabeth — Washington University
  • Study coordinator: Oldenburg, Catherine Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.